161 related articles for article (PubMed ID: 10421074)
21. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
[TBL] [Abstract][Full Text] [Related]
22. Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.
Bessell EM; López-Guillermo A; Villá S; Verger E; Nomdedeu B; Petit J; Byrne P; Montserrat E; Graus F
J Clin Oncol; 2002 Jan; 20(1):231-6. PubMed ID: 11773174
[TBL] [Abstract][Full Text] [Related]
23. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
Bessell EM; Graus F; Punt JA; Firth JL; Hope DT; Moloney AJ; Lopez-Guillermo A; Villa S
J Clin Oncol; 1996 Mar; 14(3):945-54. PubMed ID: 8622044
[TBL] [Abstract][Full Text] [Related]
24. Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Yamanaka R; Shinbo Y; Sano M; Homma J; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Morii K; Onda K; Tanaka R
Leuk Lymphoma; 2007 Jun; 48(6):1119-26. PubMed ID: 17577775
[TBL] [Abstract][Full Text] [Related]
25. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
[TBL] [Abstract][Full Text] [Related]
26. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
27. Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma.
Tanosaki R; Okamoto S; Akatsuka N; Ishida A; Michikawa N; Masuda Y; Uchida H; Murata M; Kizaki M; Ikeda Y
Cancer; 1994 Oct; 74(7):1939-44. PubMed ID: 7521788
[TBL] [Abstract][Full Text] [Related]
28. [Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)].
Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Kitaoka H
Gan To Kagaku Ryoho; 1982 Feb; 9(2):323-9. PubMed ID: 6897859
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
Takenaka T; Maruyama K; Kinoshita T; Sasako M; Sano T; Katai H; Matsuno Y
Br J Cancer; 1997; 76(11):1484-8. PubMed ID: 9400946
[TBL] [Abstract][Full Text] [Related]
30. Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Bolognesi A; Verusio C; Villa E
Eur J Cancer; 1995 Nov; 31A(12):2008-12. PubMed ID: 8562157
[TBL] [Abstract][Full Text] [Related]
31. Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone.
Brada M; Dearnaley D; Horwich A; Bloom HJ
Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):787-92. PubMed ID: 1691160
[TBL] [Abstract][Full Text] [Related]
32. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
[TBL] [Abstract][Full Text] [Related]
33. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
34. NHL-3 protocol. Six-drug combination chemotherapy for non-Hodgkin's lymphoma.
Koziner B; Sklaroff R; Little C; Labriola D; Thaler HT; Straus DJ; Young CW; Nisce LZ; Oettgen H; Lee BJ
Cancer; 1984 Jun; 53(12):2592-600. PubMed ID: 6547072
[TBL] [Abstract][Full Text] [Related]
35. Results of treatment of 112 cases of primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
[TBL] [Abstract][Full Text] [Related]
36. Lymphoma of uterine cervix.
Khoury GG; Robinson A
Eur J Surg Oncol; 1989 Feb; 15(1):65-7. PubMed ID: 2645175
[TBL] [Abstract][Full Text] [Related]
37. Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Hainsworth JD; Flinn IW; Spigel DR; Clark BL; Griner PL; Vazquez ER; Doss HH; Shipley D; Franco LA; Burris HA; Greco FA;
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):44-50. PubMed ID: 20223728
[TBL] [Abstract][Full Text] [Related]
38. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
[TBL] [Abstract][Full Text] [Related]
39. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.
Fisher B; Seiferheld W; Schultz C; DeAngelis L; Nelson D; Schold SC; Curran W; Mehta M
J Neurooncol; 2005 Sep; 74(2):201-5. PubMed ID: 16193393
[TBL] [Abstract][Full Text] [Related]
40. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
